These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Gastric tolerance of a new antirheumatic preparation]. Carrozzo M; Panella C; Loizzi P Minerva Med; 1973 Jun; 64(47):2507-10. PubMed ID: 4542021 [No Abstract] [Full Text] [Related]
43. [Anti-inflammatory or antirheumatic agents? Pharmacological activity and therapeutic effectiveness of non-steroid anti-inflammatory drugs: comparative study. III]. Mariani L; Baratelli M Clin Ter; 1980 Feb; 92(4):331-58. PubMed ID: 7004749 [No Abstract] [Full Text] [Related]
44. [Anti-inflammatory agents and rheumatic diseases. New products: why make them?]. Asch L; Camus JP; Guidet M; Peyron J; Roux H Sem Hop; 1981 Oct 18-25; 57(39-40):1581-3. PubMed ID: 6275504 [No Abstract] [Full Text] [Related]
45. [Controlled clinical study of thetherapeutic effect of the p-butoxyphenyl-acethydroxamic acid in maxillofacial surgery]. Van de Vijver LM Acta Stomatol Belg; 1969; 66(2):225-35. PubMed ID: 5255595 [No Abstract] [Full Text] [Related]
46. [Anti-rheumatic drugs or the drug therapy of rheumatic diseases]. Gross D Ther Umsch; 1972 Aug; 29(8):461. PubMed ID: 4538296 [No Abstract] [Full Text] [Related]
47. [Use of anti-inflammatory drugs in children]. Hoppu K; Korpela R Duodecim; 1994; 110(6):607-14. PubMed ID: 7555861 [No Abstract] [Full Text] [Related]
48. [Iatrogenic pathology in rheumatology]. Delrieu F Soins; 1976 Aug 5-20; 21(15-16):117-22. PubMed ID: 1085491 [No Abstract] [Full Text] [Related]
49. [Open clinical study with the antirheumatic agent 2-4 isobutyl-phenyl-propionic acid]. Ruiz Perez LC; Goiz Duran J; Gallegos Navarro CF Prensa Med Mex; 1971 Oct; 36(9):448-50. PubMed ID: 4943104 [No Abstract] [Full Text] [Related]
50. [Liocausyth. Pharmacological and clinical contribution to the anti-inflammatory, analgesic and anti-thermal action]. Minerva Med; 1967 Mar; 58(18 Suppl):721. PubMed ID: 5297785 [No Abstract] [Full Text] [Related]
51. [Incidence of undesirable side-effects in the course of controlled clinical experiments with non-steroid antirheumatic agents]. Pavelka K; Vojtísek O; Kanková D Vnitr Lek; 1978 Mar; 24(3):260-9. PubMed ID: 347697 [No Abstract] [Full Text] [Related]
52. [Pharmacological properties and therapeutic effect of azapropazon in rheumatic diseases]. Fiegel G Z Allgemeinmed; 1973 Apr; 49(12):592-4. PubMed ID: 4576254 [No Abstract] [Full Text] [Related]
53. [Ultra-Demoplas, a new highly effective antiphlogistic-analgesic preparation]. Ziegler E Ther Ggw; 1971 May; 110(5):731-2 passim. PubMed ID: 5314040 [No Abstract] [Full Text] [Related]
59. [Individual tolerance of drugs for rheumatic diseases]. Miehle W Fortschr Med; 1985 Dec; 103(47-48):1102-4. PubMed ID: 3878821 [No Abstract] [Full Text] [Related]
60. Short-term and long-term open evaluation of the efficacy and tolerance of proglumetacin, a new antirheumatic agent. Branco do Amaral A Pharmatherapeutica; 1982; 3(3):174-9. PubMed ID: 6982478 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]